CVS vs. PODD: CVS Health vs. Insulet Stock Comparison
How do CVS Health (CVS) and Insulet (PODD) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
CVS Health (CVS) and Insulet (PODD) both fall under the Health Care Equipment & Services industry group, but CVS is classified in Health Care Providers & Services while PODD is classified in Health Care Equipment & Supplies.
| Profile Item | CVS | PODD |
|---|---|---|
| Name | CVS Health Corporation Common Stock | Insulet Corporation |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Providers & Services | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Services | Health Care Equipment |
| Market Capitalization | 107.28 billion USD | 10.16 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | Nasdaq |
| Listing Date | February 21, 1973 | May 15, 2007 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | CVS | PODD |
|---|---|---|
| Total Return (1Y) | 11.41% | -53.25% |
| Total Return (3Y, Annualized) | 12.73% | -0.74% |
| Total Return (5Y, Annualized) | 1.70% | -14.02% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | CVS | PODD |
|---|---|---|
| Volatility (1Y, Annualized) | 34.14% | 46.33% |
| Beta (5Y) | 0.60 | 1.04 |
| Max Drawdown (5Y) | -56.79% | -63.02% |
| Avg. Volume (3M) | 8.60M | 1.58M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | CVS | PODD |
|---|---|---|
| Sharpe Ratio (1Y) | 0.21 | -1.24 |
| Sortino Ratio (1Y) | 0.28 | -1.51 |
Profitability
ROE (TTM)
Insulet (PODD) at 28.94% sits in the top ROE quartile, while CVS Health (CVS) at 14.36% is closer to the peer norm — stronger capital efficiency for PODD.
CVS
Health Care Equipment & Services industry group
14.36%
- Max
- 47.61%
- CVS
- 14.36%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
PODD
Health Care Equipment & Services industry group
28.94%
- Max
- 47.61%
- PODD
- 28.94%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Insulet (PODD) at 13.44% retains a top-quartile share of revenue as profit, ahead of CVS Health (CVS) at 2.64%, which keeps about the industry-typical share.
CVS
Health Care Equipment & Services industry group
2.64%
- Max
- 29.35%
- Q3
- 9.33%
- CVS
- 2.64%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
PODD
Health Care Equipment & Services industry group
13.44%
- Max
- 29.35%
- PODD
- 13.44%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Insulet (PODD) at 22.54% operates in the top operating margin quartile, ahead of CVS Health (CVS) at 2.72%, which runs around its industry’s norm.
CVS
Health Care Equipment & Services industry group
2.72%
- Max
- 35.43%
- Q3
- 14.14%
- Median
- 6.81%
- CVS
- 2.72%
- Q1
- -0.28%
- Min
- -16.29%
PODD
Health Care Equipment & Services industry group
22.54%
- Max
- 35.43%
- PODD
- 22.54%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | CVS | PODD |
|---|---|---|
| ROE (TTM) | 14.36% | 28.94% |
| ROA (TTM) | 3.11% | 11.40% |
| Net Margin (TTM) | 2.64% | 13.44% |
| Operating Margin (TTM) | 2.72% | 22.54% |
| Gross Margin (TTM) | 13.72% | 71.88% |
Growth
Revenue Growth
Insulet (PODD) at 30.73% sits in the top revenue growth quartile, while CVS Health (CVS) at 7.85% is closer to the peer norm — faster top-line expansion for PODD.
EPS Growth
Both CVS Health (CVS) at -62.02% and Insulet (PODD) at -39.79% post bottom-quartile EPS growth versus peers, pointing to weaker earnings momentum than typical rivals.
Growth Metrics
| Metric | CVS | PODD |
|---|---|---|
| Revenue Growth (YoY) | 7.85% | 30.73% |
| Revenue Growth (3Y CAGR) | 7.63% | 27.54% |
| EPS Growth (YoY) | -62.02% | -39.79% |
| EPS Growth (3Y CAGR) | -24.73% | 267.70% |
Financial Strength
Current Ratio (MRQ)
Insulet (PODD) at 2.51 keeps current ratio within its industry’s typical mid-range, while CVS Health (CVS) at 0.85 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for CVS.
CVS
Health Care Equipment & Services industry group
0.85
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- CVS
- 0.85
- Min
- 0.30
PODD
Health Care Equipment & Services industry group
2.51
- Max
- 7.59
- Q3
- 4.00
- PODD
- 2.51
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Insulet (PODD) at 0.66 carries an industry-typical debt-to-equity mix, while CVS Health (CVS) at 0.93 uses more debt funding than most peers.
CVS
Health Care Equipment & Services industry group
0.93
- Max
- 1.88
- CVS
- 0.93
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
PODD
Health Care Equipment & Services industry group
0.66
- Max
- 1.88
- Q3
- 0.91
- PODD
- 0.66
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | CVS | PODD |
|---|---|---|
| Current Ratio (MRQ) | 0.85 | 2.51 |
| Debt / Equity (MRQ) | 0.93 | 0.66 |
| Net Debt / EBITDA | 3.49 | 0.65 |
Dividends
Dividend Yield (TTM)
Insulet (PODD) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile CVS Health (CVS) reports a yield of 3.27%, ranking against industry peers normally.
CVS
Health Care Equipment & Services industry group
3.27%
- CVS
- 3.27%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
PODD
Health Care Equipment & Services industry group
0.00%
- PODD
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Insulet (PODD) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile CVS Health (CVS) reports a payout of 30.89%, ranking against industry peers normally.
CVS
Health Care Equipment & Services industry group
30.89%
- CVS
- 30.89%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
PODD
Health Care Equipment & Services industry group
0.00%
- PODD
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | CVS | PODD |
|---|---|---|
| Dividend Yield (TTM) | 3.27% | 0.00% |
| Dividend Payout Ratio (TTM) | 30.89% | 0.00% |
Valuation
P/E Ratio (TTM)
CVS Health (CVS) at 9.74 sits in the cheaper P/E ratio quartile, while Insulet (PODD) at 23.94 is closer to its industry’s usual earnings multiple — a discount for CVS, though growth and earnings durability still matter.
CVS
Health Care Equipment & Services industry group
9.74
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- CVS
- 9.74
- Min
- 4.21
PODD
Health Care Equipment & Services industry group
23.94
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- PODD
- 23.94
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
CVS Health (CVS) at 0.26 sits in the cheaper P/S ratio quartile while Insulet (PODD) at 3.19 prices around its industry’s middle — CVS costs less per dollar of sales, though read it alongside growth and margins.
CVS
Health Care Equipment & Services industry group
0.26
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- CVS
- 0.26
- Min
- 0.03
PODD
Health Care Equipment & Services industry group
3.19
- Max
- 8.80
- Q3
- 4.32
- PODD
- 3.19
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
CVS Health (CVS) at 1.33 looks cheap against book in the lower P/B ratio quartile, while Insulet (PODD) at 6.44 carries a premium in the upper quartile — a clear price-to-book gap.
CVS
Health Care Equipment & Services industry group
1.33
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- CVS
- 1.33
- Min
- -1.31
PODD
Health Care Equipment & Services industry group
6.44
- Max
- 11.68
- PODD
- 6.44
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | CVS | PODD |
|---|---|---|
| P/E Ratio (TTM) | 9.74 | 23.94 |
| P/S Ratio (TTM) | 0.26 | 3.19 |
| P/B Ratio (MRQ) | 1.33 | 6.44 |
| Free Cash Flow Yield (TTM) | 11.02% | 1.12% |